Fust Lab Launches Full-Scale Focused Ultrasound Driven ‘Surfactant Free’ Cosmetics ODM Project

양대선 기자 / 기사승인 : 2026-02-11 09:30:43

[메가경제=양대선 기자] Fust Lab, a company specializing in focused ultrasound technology, announced the full-scale rollout of its surfactant-free cosmetics original design manufacturing (ODM) project driven by focused ultrasound processing technology.

 

DEBREX is a platform that maximizes nano-emulsification and dispersion through high-intensity focused ultrasound. By enabling emulsification, uniform particle dispersion, and hypoallergenic, high-performance formulations even without surfactants, it is recognized as a unique, surfactant-free manufacturing process compared to traditional mechanical agitation or high-shear mixing.


When the technology is adopted in formulation development, it can drastically improve the absorption and sensory profile of cosmetics by achieving stable emulsification without chemical surfactants. It expects to gain a competitive edge in the sensitive skin care market which demand the minimization of skin irritation.


Moving beyond simple technology-based OEM manufacturing, Fust Lab has expanded its business model from surfactant-free design stages to full-scale ODM model, offering a novel technological alternative for the cosmetics manufacturing process.


In fact, since last year, it has been developing various formulations and conducting sample testing of surfactant-free creams and emulsions targeting domestic cosmetic brands and manufacturers. Samples have been delivered to major domestic cosmetic brands, including Celltrion, AHC, and LG Household & Healthcare, receiving feedback of “superior absorption with silky smooth texture and even application”. Currently, it is optimizing product quality by precisely customizing the viscosity, particle distribution, and sensory profiles of surfactant-free formulations to meet client requirements, while simultaneously conducting safety assessments.
It is currently working on improving its level of qualities through making precise customization of viscosity, particle distribution and sensory profiles for surfactant-free formulation tailored to clients’ requirement and safety assessment simultaneously.


Building on these achievements, it is establishing a foundation for global testing and strategic partnership to scale its surfactant-free cosmetic ODM business. Supported by the global expansion program of Seoul Startup Hub Gongdeok, the company laid the groundwork for international growth. Following a contract with Hyundai Corporation’s German subsidiary, Fust Lab has established a demo-room in Frankfurt, where it is currently conducting PoC for its cosmetics and raw materials targeting European clients.


The progress in Japan is also becoming increasingly evident. Since establishing its Japanese subsidiary last October, the company has been supplying demo equipment and conducting joint testing with local companies, including Meiji, Hitachi High-Tech, and Resonac. In fact, these efforts have already borne fruit, with Meiji placing a purchase order for equipment after recognizing the excellence of the company’s surfactant-free emulsification testing results.


Fust Lab aims to successfully conclude surfactant-free cosmetic testing for both domestic and international clients in the first half of this year, materializing its achievements in the cosmetic ODM business. Building on these milestones, it will expand its surfactant-free cosmetic ODM business across European and Japanese markets, while securing Series A funding for further accelerate its growth.


Officials at Fust Lab stated, “Surfactant-free cosmetic ODM business, driven by focused ultrasound technology, is the core engine for the growth. Moving beyond technical PoC, we are now entering the next phase, full-scale production and the realization of tangible business achievements”.


Meanwhile, driven by its surfactant-free cosmetic ODM projects and advancements in focused ultrasound technology, Fust Lab secured 3.1 billion KRW in funding last year, bringing its total investment to 6.6 billion KRW. Furthermore, the company continues to build its reputation as a technology-driven company by securing various accolades, such as winning the CES Innovation Awards for two consecutive years, being named a nominee for the Edison Awards, and winning the Shinhan ESG Demo Day.

[저작권자ⓒ 메가경제. 무단전재-재배포 금지]

뉴스댓글 >

최신기사

1

대웅제약 씽크, 안산 클래스병원 진입…90병상 스마트 모니터링 구축
[메가경제=김민준 기자] 척추·관절 수술 환자의 회복 과정에서 생체신호를 연속적으로 확인할 수 있는 스마트병동 환경이 안산 지역 의료기관에 구축됐다. 대웅제약은 클래스병원 90병상에 인공지능(AI) 기반 스마트 병상 모니터링 시스템을 공급하고, 입원 환자의 생체신호를 실시간으로 확인할 수 있는 체계를 마련했다. 30일 대웅제약에 따르면 회사는 최근 클래

2

대웅제약, 13개 파트너사와 AI 스마트병원 구현…디지털헬스케어 확장
[메가경제=김민준 기자] 대웅제약이 의료기관과 디지털헬스케어 기업을 연결해 인공지능(AI) 기반 스마트병원 모델을 선보인다. 생체신호 모니터링부터 진단·검사, 재활치료까지 의료 과정별 기술을 하나의 병원 환경에 구현하고, 병원 내 디지털 전환을 지역사회 건강관리로 확장하는 협력 모델을 제시한다. 30일 대웅제약에 따르면 회사는 오는 11월 3일부터 5일까지

3

최병민 고려대 안산병원 교수, 대한소아청소년과학회 회장 취임
[메가경제=김민준 기자] 고려대학교 안산병원 소아청소년과 최병민 교수가 대한소아청소년과학회 제66대 회장에 취임한다. 임기는 2026년 11월부터 2027년 10월까지 1년이다. 최 교수는 신생아학 분야의 전문가로, 오랜 기간 미숙아와 고위험 신생아의 진료와 교육에 매진하며 신생아 집중치료 발전에 힘써왔다. 또한 신생아 혈역학 및 신생아 영상 AI 판독 알

HEADLINE

더보기

트렌드경제

더보기